13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-04-13 Event 2026-02-03 SEC 0002126287-26-000001 →

International Generosity Foundation Trust → Barinthus Biotherapeutics plc. BRNS

Stake: 6.70% Shares: 2,734,189 CUSIP: 91864C107 Class: Common Stock
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 23/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -15.6%
  • Active Schedule 13D filer baseline
  • Short interest building (+46.2% vs prior settlement)

Item 4 — Purpose of Transaction

The Reporting Person acquired the securities for investment purposes and in connection with its charitable activities. The Reporting Person may, from time to time, sell or otherwise dispose of some or all of the securities, including to support its charitable purposes, or acquire additional securities, depending on market conditions and other factors. Except as set forth above, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Schedule 13D.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 1.00
13,211 shares short · +46.2% vs prior

Post-Filing Returns · since 2026-02-03 on BRNS

+1 day
-6.0%
+5 days
-5.0%
+30 days
-20.7%
+60 days
-23.6%
+90 days
-15.6%
+180 days
—

Anchor price 0.75 on closest trading day on/after 2026-02-03. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →